trending Market Intelligence /marketintelligence/en/news-insights/trending/dqynTxRdw3PAb7YNfetzZg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Australia's DorsaVi to cut operational costs, focus on existing products

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Australia's DorsaVi to cut operational costs, focus on existing products

Australia's DorsaVi Ltd. has taken measures to cut costs, which will reduce cash outflows from operating activities by 30% to 40% compared to the first half of 2019.

The measures include reducing staff in corporate and support services and focusing on existing product portfolio rather than developing additional products.

In addition, the Kew, Victoria-based company plans to prioritize increasing direct sales capability in the U.S. workplace and clinical market.

DorsaVi's said its senior management is taking a voluntary reduction in salaries, with CEO Andrew Ronchi agreeing to reduce his pay and benefits from $310,000 to $221,500.

Further, the company's nonexecutive directors have agreed, subject to shareholder approval, to accept stock options as their fees starting from March 1.

DorsaVi makes wearable sensors to measure movement and muscle activation for use in treating sports injuries and assist in athletic training and recovery.